Russia licensed the two-shot vaccine for domestic use in August and before any data had been published or a large-scale trial begun
Moscow — Russia's “Sputnik-V” Covid-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published on Friday by The Lancet medical journal that were hailed by Moscow as an answer to its critics.
“Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing Covid-19 infection,” it said. “All of the boxes are checked,” he told Reuters. “Now ... we will start asking questions of some of the Western vaccines.”
More than half a dozen drugmakers are already conducting advanced clinical trials, each with tens of thousands of participants and several, including Britain’s AstraZeneca and US drugmakers Moderna and Pfizer expect to know if their Covid-19 vaccines work and are safe by the end of this year.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Russia hails Lancet review of early-stage trials of Sputnik-V Covid-19 vaccineRussia licensed the two-shot vaccine for domestic use in August and before any data had been published or a large-scale trial begun
Read more »
Results of Russia's Covid-19 vaccine produced antibody response - The LancetRussia's 'Sputnik-V' Covid-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published on Friday by The Lancet medical journal that were hailed by Moscow as an answer to its critics.
Read more »
Russia asks Germany for copious details of poison tests on NavalnyRussia has asked Germany to provide exhaustive details of medical tests conducted on Alexei Navalny, a Russian opposition politician lying in a coma in Berlin after a suspected poisoning in Siberia last month, a newspaper reported on Wednesday.
Read more »
Russia hails Lancet review of early-stage trials of Sputnik-V Covid-19 vaccineRussia licensed the two-shot vaccine for domestic use in August and before any data had been published or a large-scale trial begun
Read more »
Results of Russia's Covid-19 vaccine produced antibody response - The LancetRussia's 'Sputnik-V' Covid-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published on Friday by The Lancet medical journal that were hailed by Moscow as an answer to its critics.
Read more »